Novozymes A/S's ticker is NVZMY and the CUSIP is 670108109. A total of 6 filers reported holding Novozymes A/S in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $252 | -99.9% | 5,000 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $300,000 | 0.0% | 5,000 | 0.0% | 0.02% | 0.0% |
| Q2 2022 | $300,000 | -12.5% | 5,000 | 0.0% | 0.02% | +5.3% |
| Q1 2022 | $343,000 | -17.5% | 5,000 | 0.0% | 0.02% | -17.4% |
| Q4 2021 | $416,000 | +21.6% | 5,000 | 0.0% | 0.02% | +9.5% |
| Q3 2021 | $342,000 | -9.3% | 5,000 | 0.0% | 0.02% | -12.5% |
| Q2 2021 | $377,000 | +17.4% | 5,000 | 0.0% | 0.02% | +9.1% |
| Q1 2021 | $321,000 | +12.6% | 5,000 | 0.0% | 0.02% | +10.0% |
| Q4 2020 | $285,000 | -9.5% | 5,000 | 0.0% | 0.02% | -23.1% |
| Q3 2020 | $315,000 | +9.0% | 5,000 | 0.0% | 0.03% | +4.0% |
| Q2 2020 | $289,000 | +27.3% | 5,000 | 0.0% | 0.02% | +13.6% |
| Q1 2020 | $227,000 | -7.0% | 5,000 | 0.0% | 0.02% | +10.0% |
| Q4 2019 | $244,000 | +16.2% | 5,000 | 0.0% | 0.02% | -13.0% |
| Q3 2019 | $210,000 | – | 5,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lenox Wealth Management, Inc. | 70,039 | $3,834,000 | 1.14% |
| GARRISON BRADFORD & ASSOCIATES INC | 15,100 | $827,000 | 0.67% |
| Moloney Securities Asset Management, LLC | 31,722 | $1,742,000 | 0.60% |
| ZEVIN ASSET MANAGEMENT LLC | 34,729 | $1,901,000 | 0.56% |
| HIGH POINTE CAPITAL MANAGEMENT LLC | 6,490 | $356,000 | 0.48% |
| BOSTON FINANCIAL MANGEMENT LLC | 102,687 | $5,621,000 | 0.33% |
| Boston Common Asset Management, LLC | 18,656 | $1,025,000 | 0.13% |
| Hemenway Trust Co LLC | 12,000 | $657,000 | 0.11% |
| QUADRANT CAPITAL GROUP LLC | 2,011 | $104,000 | 0.03% |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 261,819 | $14,332,000 | 0.01% |